Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control

Introduction The selection of an optimal maintenance agent in diffuse large B-cell lymphoma (DLBCL) continues to pose a significant clinical challenge. This study aims to evaluate the prognostic impact of maintenance therapy (MT) in DLBCL.Methods We conducted a retrospective analysis of data from DL...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Li-Wei Lyu, Na Yao, Zi-Xian Liu, Yan-Ying Wang, Jie Li, He-Bing Zhou, Li-Hong Li, Zhen-Ling Li, Liang Wang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Taylor & Francis Group 2026-12-01
Rangatū:	Cancer Biology & Therapy
Ngā marau:	Diffuse large B-cell lymphoma maintenance therapy survival BTKi central nervous system
Urunga tuihono:	https://www.tandfonline.com/doi/10.1080/15384047.2026.2662031
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!